Invesco S&P 500 Equal Weight Consumer Staples ETF
RHS
New York Stock Exchange Arca- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Invesco S&P 500 Equal Weight Consumer Staples ETF (RHS) is an exchange-traded fund that seeks to track the performance, before fees and expenses, of the S&P 500 Equal Weight Consumer Staples Index. The fund invests at least 90% of its total assets in common stocks comprising the underlying index, which equally weights all S&P 500 consumer staples sector constituents across sub-industries including food and drug retailing, beverages, food products, tobacco, household products, and personal products. It employs a passive replication management strategy to mirror the equal-weighted index, providing diversified exposure to U.S. consumer staples equities with approximately 98% of holdings in United States-based companies. RHS operates within the asset management industry's exchange-traded funds segment, targeting investors seeking defensive sector allocation in consumer staples; key holdings as of early 2025 include Walgreens Boots Alliance Inc., Walmart Inc., Philip Morris International Inc., The Estee Lauder Companies Inc., and Dollar Tree Inc. The ETF is issued by Invesco Ltd., an independent investment management firm founded in 1935 and headquartered in Atlanta, Georgia. Invesco, which manages ETFs under brands including Invesco and PowerShares, maintains operations in over 20 countries globally. Recent developments for RHS include quarterly distributions, such as $0.1885 declared in mid-2025, amid ongoing portfolio adjustments reflecting sector dynamics like short interest surges in consumer staples during 2024-2025. The fund has navigated broader Invesco strategic shifts, including criticism in February 2025 from 17 U.S. state attorneys general over China investment disclosures, though no direct operational changes to RHS were reported. No major acquisitions, partnerships, or product launches specific to RHS occurred in the last 1-2 years, with focus remaining on index replication amid stable AUM and performance tracking.